Ulrik B Dragsted

Summary

Affiliation: Hvidovre University Hospital
Country: Denmark

Publications

  1. ncbi request reprint [HIV resistance testing. Introduction of a new technique]
    Ulrik Bak Dragsted
    infektionsmedicinsk afdeling 144, H S Hvidovre Hospital, Kettegard Alle 30, DK 2650 Hvidovre
    Ugeskr Laeger 164:2263-7. 2002
  2. ncbi request reprint Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
    Ulrik Bak Dragsted
    Hvidovre University Hospital, Hvidovre, Denmark
    J Infect Dis 188:635-42. 2003
  3. ncbi request reprint Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study
    Ulrik Bak Dragsted
    Hvidovre University Hospital, Copenhagen, Denmark
    J Infect Dis 190:148-55. 2004
  4. ncbi request reprint A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial
    Ulrik B Dragsted
    Hvidovre University Hospital, Copenhagen, Denmark
    Antivir Ther 10:735-43. 2005
  5. ncbi request reprint A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial
    Zoe Fox
    Copenhagen HIV Programme CHIP, Hvidovre University Hospital, Copenhagen, Denmark
    Antivir Ther 11:761-70. 2006
  6. ncbi request reprint Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study
    Daria Podlekareva
    Hvidovre University Hospital, Kettegaard Alle 30, DK 2650 Hvidovre, Denmark
    J Infect Dis 194:633-41. 2006
  7. ncbi request reprint The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors
    Zoe V Fox
    Copenhagen HIV Programme, Medical Faculty at University of Copenhagen, Denmark
    AIDS 21:2033-42. 2007

Detail Information

Publications7

  1. ncbi request reprint [HIV resistance testing. Introduction of a new technique]
    Ulrik Bak Dragsted
    infektionsmedicinsk afdeling 144, H S Hvidovre Hospital, Kettegard Alle 30, DK 2650 Hvidovre
    Ugeskr Laeger 164:2263-7. 2002
    ..Genotypic resistance testing can also be used for epidemiological surveillance...
  2. ncbi request reprint Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
    Ulrik Bak Dragsted
    Hvidovre University Hospital, Hvidovre, Denmark
    J Infect Dis 188:635-42. 2003
    ..A greater number of treatment-limiting adverse events were observed in the Idv/Rtv arm, relative to the Sqv/Rtv arm. In conclusion, Rtv-boosed Sqv and Idv were found to have comparable antiretroviral effects in the doses studied...
  3. ncbi request reprint Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study
    Ulrik Bak Dragsted
    Hvidovre University Hospital, Copenhagen, Denmark
    J Infect Dis 190:148-55. 2004
    ..Factors that determine the immunological response to highly active antiretroviral therapy (HAART) are poorly defined...
  4. ncbi request reprint A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial
    Ulrik B Dragsted
    Hvidovre University Hospital, Copenhagen, Denmark
    Antivir Ther 10:735-43. 2005
    ..To assess the rate of protocol-defined treatment failure and safety of lopinavir/ritonavir (LPV/r) and saquinavir/ritonavir (SAQ/r)...
  5. ncbi request reprint A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial
    Zoe Fox
    Copenhagen HIV Programme CHIP, Hvidovre University Hospital, Copenhagen, Denmark
    Antivir Ther 11:761-70. 2006
    ..No data exist from clinical comparative studies evaluating the benefit of M1841/V in patients receiving combination antiretroviral therapy (cART)...
  6. ncbi request reprint Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study
    Daria Podlekareva
    Hvidovre University Hospital, Kettegaard Alle 30, DK 2650 Hvidovre, Denmark
    J Infect Dis 194:633-41. 2006
    ..Limited data exist on factors predicting the development of opportunistic infections (OIs) at higher-than-expected CD4(+) cell counts in human immunodeficiency virus (HIV) type 1-infected adults...
  7. ncbi request reprint The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors
    Zoe V Fox
    Copenhagen HIV Programme, Medical Faculty at University of Copenhagen, Denmark
    AIDS 21:2033-42. 2007
    ..We compared PI/r resistance levels ascribed by four GIS and examined their abilities to predict HIV-RNA reductions after starting a PI/r-based regimen (baseline)...